Advertisement
U.S. markets open in 1 hour 59 minutes

OpGen, Inc. (OPGN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.4240+0.0110 (+2.66%)
At close: 03:42PM EST
0.4200 -0.00 (-0.94%)
Pre-Market: 07:04AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close0.4130
Open0.4199
Bid0.3800 x 800
Ask0.0000 x 1400
Day's Range0.4165 - 0.4350
52 Week Range0.1650 - 3.8400
Volume77,285
Avg. Volume188,027
Market Cap4.246M
Beta (5Y Monthly)-0.90
PE Ratio (TTM)N/A
EPS (TTM)-6.2500
Earnings DateMar 27, 2024 - Apr 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for OPGN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • OpGen, Inc.
    Daily – Vickers Top Buyers & Sellers for 02/23/2024The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • GlobeNewswire

    OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update

    Total revenue for the first nine months of 2023 was approximately $2.35 million compared to approximately $1.89 million in the first nine months of 2022Implemented certain cash management initiatives, including restructuring U.S. operations by reducing headcount during the third quarter of 2023Signed preferred stock purchase agreement with a potential strategic investor in October 2023Entered into a warrant inducement agreement with an institutional investor in October 2023Subsidiaries Curetis G

  • GlobeNewswire

    OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds

    ROCKVILLE, Md., Oct. 12, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that it has entered into an agreement with an institutional investor that is an existing holder of warrants to purchase common shares of the Company for cash (the “Existing Warrants”), wherein the investor agreed to exercise the Existing Warrants to pur

  • Benzinga

    ChatGPT Parent OpenAI Aims At Budget-Friendly AI Innovations, Novo Nordisk's Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany: Today's Top Stories

    Bloomberg Apple and Suppliers Face Unanticipated Sales Slump Despite New Launches In a surprising turn of events, Apple Inc (NASDAQ: AAPL) and its key suppliers in Taiwan are facing a significant sales slump despite the recent launch of the new iPhone and various Android devices. Taiwan Semiconductor Manufacturing Co (NYSE: TSM), the leading contract chipmaker, experienced a 13.4% sales drop, a figure that, while concerning, is better than initially feared. Arm's Chinese Fortunes in Jeopardy? In